Comparison · NCT00023595-bf4b7d98
Total H01: Medication + CABG vs H01: Medication: H01: Cardiovascular Mortality (Defined as Sudden Death or Death Attributed to Recurrent MI, HF, a Cardiovascular Procedure, Stroke, or Other Cardiovascular Etiology).
Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.
2 sourcestrial-comparisons-2026-03-23-0.1.0
Cite this record
ConductScience Library. Total H01: Medication + CABG vs H01: Medication: H01: Cardiovascular Mortality (Defined as Sudden Death or Death Attributed to Recurrent MI, HF, a Cardiovascular Procedure, Stroke, or Other Cardiovascular Etiology). Trial comparisons, record NCT00023595-bf4b7d98. Release trial-comparisons-2026-03-23-0.1.0, 23 Mar 2026. https://conductscience.org/library/comparisons/NCT00023595-bf4b7d98
On this page
Measures6
Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.
| Measure | Value | 95% interval, lower | 95% interval, upper | Method | Note |
|---|---|---|---|---|---|
| Risk in group 1 | 0.405 | 0.367 | 0.444 | wilson | |
| Risk in group 2 | 0.493 | 0.454 | 0.533 | wilson | |
| Risk difference, group 1 minus group 2 | -0.0884 | -0.144 | -0.0324 | newcombe hybrid score | |
| Risk ratio, group 1 over group 2 | 0.821 | 0.724 | 0.931 | log | |
| Odds ratio, group 1 over group 2 | 0.699 | 0.557 | 0.877 | log | |
| Number needed to treat, for one fewer participant with the outcome on Total H01: Medication + CABG than on H01: Medication | 11.3 | 6.96 | 30.8 | from the risk difference interval |
Source ClinicalTrials.gov
Groups2
Neither group, or both, names a comparator, so the groups keep ClinicalTrials.gov's order.
| Group | Title | Description | With the outcome | Analysed | ClinicalTrials.gov code |
|---|---|---|---|---|---|
| Group 1 | Total H01: Medication + CABG | H01 patients were randomized to medical therapy plus CABG. In addition to the guideline-recommended medications, coronary artery bypass graft (CABG) surgery was to be performed for patients randomized to this treatment arm.~The Total H01: Medication + CABG group includes the H01: Medication + CABG group and those 76 patients who belong to H01+H02: Medication + CABG arm. | 247 | 610 | OG000 |
| Group 2 | H01: Medication | H01 patients were randomized to medical therapy alone. Throughout the trial follow-up period, the use of guideline-recommended medications and devices for the treatment of heart failure and CAD was strongly emphasized for all patients in this treatment arm. | 297 | 602 | OG001 |
Source ClinicalTrials.gov
Outcome
- Type
- SECONDARY
- Title
- H01: Cardiovascular Mortality (Defined as Sudden Death or Death Attributed to Recurrent MI, HF, a Cardiovascular Procedure, Stroke, or Other Cardiovascular Etiology).
- Description
- Time frame
- 10 years post randomization
- Population
- The Total H01: Medication + CABG group includes the H01: Medication + CABG group and those 76 patients who belong to H01+H02: Medication + CABG arm.
Source ClinicalTrials.gov
Trial
- Title
- Comparison of Surgical and Medical Treatment for Congestive Heart Failure and Coronary Artery Disease
- NCT number
- NCT00023595
- Phases
- PHASE3
- Conditions
- Cardiovascular Diseases, Coronary Disease, Heart Failure, Congestive, Heart Diseases
- Interventions
- CABG surgery plus MED, Active Medication Alone, CABG plus MED and SVR
- Lead sponsor
- Duke University
- Results first posted
- 2017-07-24
- Results on ClinicalTrials.gov
- https://clinicaltrials.gov/study/NCT00023595?tab=results
Source ClinicalTrials.gov
Source
- Release
- trial-comparisons-2026-03-23-0.1.0
- Release manifest SHA-256
- f66225897fbf258b57ea10bdacfd0347d3cdfda93f7f5685234b7e06ea36fa57
- AACT copy
- 2026-03-23
- Tables read
- outcome_counts.parquet, outcome_measurements.parquet, outcomes.parquet, reported_event_totals.parquet, reported_events.parquet, result_groups.parquet, studies.parquet, ctgov_trial.parquet
Source ClinicalTrials.gov
Sources 2
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.
For software
Read this comparison from software.
The record is JSON. No key.
GET https://conductscience.org/api/comparisons/v1/NCT00023595-bf4b7d98